Krupa Shukla
Overview
Explore the profile of Krupa Shukla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shukla K, Ferraris D, Thomas A, Stathis M, Duvall B, Delahanty G, et al.
J Med Chem
. 2012 Nov;
55(23):10551-63.
PMID: 23151085
Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a potent and selective allosteric inhibitor of kidney-type glutaminase (GLS) that has served as a molecular probe to determine the therapeutic potential of GLS inhibition. In...
2.
Shukla K, Thomas A, Ferraris D, Hin N, Sattler R, Alt J, et al.
Bioorg Med Chem Lett
. 2011 Sep;
21(20):6184-7.
PMID: 21889337
A series of sulfasalazine analogs were synthesized and tested for their ability to block cystine-glutamate antiporter system xc⁻ using L-[(14)C]cystine as a substrate. Replacement of sulfasalazine's diazo group with an...
3.
Grella B, Adams J, Berry J, Delahanty G, Ferraris D, Majer P, et al.
Bioorg Med Chem Lett
. 2010 Nov;
20(24):7222-5.
PMID: 21074428
A series of N-substituted 3-(2-mercaptoethyl)-1H-indole-2-carboxylic acids were synthesized as inhibitors of glutamate carboxypeptidase II (GCPII). Those containing carboxybenzyl or carboxyphenyl groups at the N-position exhibited potent inhibitory activity against GCPII....